Cardiac-troponin-guided heart failure management: is it possible in clinical practice?

Inomata T

首页> 外文期刊>Circulation journal >Cardiac-troponin-guided heart failure management: is it possible in clinical practice?

【24h】

Cardiac-troponin-guided heart failure management: is it possible in clinical practice?

机译：心肌肌钙蛋白指导的心力衰竭管理：在临床实践中可能吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Biomarker-based management has been increasing in clinical practice because of its advantages, which include high reproducibility, and simplicity in handling and interpreting results, even by non-specialists. B-type natriuretic peptide (BNP) is established as a representative biomarker in the field of heart failure (HF), indicating the effectiveness of diagnosis and risk stratification together with screening of cardiac dysfunction and guiding optimal treatment. A recent published guideline for HF biomarkers states class I-II indication of BNP measurement for HF management. Although this guideline mostly concentrates on the usefulness of BNP, an exceptional reference was made to the contribution of cardiac troponins (cTn) in prognostic judgment as class Hb, presumably due to low evidence levels.

机译：基于生物标志物的管理在临床实践中一直在不断发展，因为它的优点包括高可重复性，以及即使非专业人员也可轻松处理和解释结果。 B型利钠肽（BNP）被确立为心力衰竭（HF）领域的代表生物标志物，表明诊断和风险分层的有效性以及对心脏功能障碍的筛查和指导最佳治疗。 HF生物标志物的最新发布指南规定了用于HF管理的BNP测量的I-II级指示。尽管该指南主要集中在BNP的用途上，但还是由于心脏钙蛋白（cTn）在Hb类的预后判断中的贡献而被特别引用，这可能是由于证据水平较低。

著录项

来源
《Circulation journal》 |2011年第3期|共2页
作者
Inomata T;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Cardiac-troponin-guided heart failure management: is it possible in clinical practice? [J] . Inomata T Circulation journal . 2011,第3期

机译：心肌肌钙蛋白指导的心力衰竭管理：在临床实践中可能吗？
2. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America (vol 134, pg e282, 2016) [J] . Yancy Circulation: An Official Journal of the American Heart Association . 2016,第13期

机译：2016年ACC / AHA / HFSA重点更新心力衰竭的新药理疗法：2013年ACCF / AHA心力衰竭治疗指南的更新：美国心脏病学会基金会/美国心脏协会临床实践工作组的报告指南与美国心力衰竭学会（vol 134，pg e282，2016）
3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America [J] . Yancy Clyde W., Jessup Mariell, Bozkurt Biykem, Circulation: An Official Journal of the American Heart Association . 2016,第13期

机译：2016年ACC / AHA / HFSA重点更新了用于心力衰竭的新药理疗法：2013年ACCF / AHA心力衰竭管理指南的更新美国心脏病学会/美国心脏协会工作组关于临床实践指南和美国心力衰竭学会
4. Clinical characteristics, management, and outcomes of patients with high risk chronic heart failure referred to a heart failure clinic in Saudi Arabia [C] . Waleed M.A. World Congress on Heart Disease. . 2013

机译：高危慢性心力衰竭患者的临床特征，管理和结果提及沙特阿拉伯的心力衰竭诊所
5. The Effectiveness of a Heart Failure Disease Management Programme on Clinical Outcomes, Health-related Quality of Life, and Psychological Status of Patients with Heart Failure in China. [D] . Yu, Mingming. 2011

机译：心力衰竭疾病管理计划对中国心力衰竭患者的临床结果，健康相关生活质量和心理状况的有效性。
6. Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? [O] . F D Hobbs 2000

机译：心力衰竭的管理：证据与实践。当前的处方是否可以为心力衰竭患者提供最佳治疗？
7. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary A report of the american college of cardiology/american heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the international society for heart and lung transplantation endorsed by the heart failure society of america51The document was approved by the American College of Cardiology Board of Trustees in November 2001 and the American Heart Association Science Advisory and Coordinating Committee in September 2001.52When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101–13.53The American College of Cardiology and the American Heart Association make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.54This document, as well as the corresponding full-text guidelines, is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Single reprints of the executive summary are available for $5.00 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org (specify version: Executive Summary—71-0125; Full Text—71-1026).55© 2001 American College of Cardiology and American Heart Association, Inc. [O] . Hunt Sharon A, Baker David W, Chin Marshall H, 2001

机译：ACC / AHA成人慢性心力衰竭评估和管理指南：执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（委员会修订1995年心脏评估和管理指南与美国心力衰竭学会认可的国际心脏和肺移植协会合作51）该文件于2001年11月获得美国心脏病学会理事会的批准，并于2001年9月获得美国心脏协会科学咨询和协调委员会的批准.52引用本文件时，美国心脏病学会和美国心脏协会将赞赏以下引用格式：Hunt SA，Baker DW，Chin MH，Cinquegrani MP，Feldman AM，Francis GS，Ganiats TG，Goldstein S，Gregoratos G，Jessup ML，Noble RJ，Packer M，Silver MA，Stevenson LW。 ACC / AHA成人慢性心力衰竭评估和管理指南：摘要：美国心脏病学会/美国心脏协会实践指南工作组的报告（修订1995年《美国心脏病学会评估和管理指南》的委员会心脏衰竭）。 J Am Coll Cardiol 2001; 38：2101–13.53美国心脏病学会和美国心脏协会竭尽全力避免由于外部关系或个人，专业或其他原因而引起的任何实际或潜在的利益冲突。写作小组成员的商业利益。具体而言，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上口头报告给写作小组的所有成员，并在发生变化时进行更新。54本文档以及相应的全文指南可在万维网上找到。美国心脏病学院（www.acc.org）和美国心脏协会（www.americanheart.org）的网站。致电800-253-4636（仅适用于美国）或写信给美国心脏病，教育服务学院，地址为9111 Old Georgetown Road，Bethesda，MD 20814-1699，可以执行摘要的单个重印本，每张5.00美元。要购买最多999份的其他重印本，请致电800-611-6083（仅限美国）或传真413-665-2671； 1000或更多副本，请致电214-706-1466，传真214-691-6342或电子邮件pubauth@heart.org（指定版本：执行摘要-71-0125；全文-71-1026）。55©2001美国心脏病学会和美国心脏协会有限公司
8. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11; Heart Failure: Management of Patients with Left-Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians No. 11; Living with Heart Disease: Is It Heart Failure. Patient and Family Guide [R] . 1994

机译：心力衰竭：左心室收缩功能障碍患者的评估和护理。临床实践指南第11号;心力衰竭：左心室收缩功能障碍患者的治疗。临床医生快速参考指南第11号;与心脏病共存：是心衰吗？患者和家庭指南

Cardiac-troponin-guided heart failure management: is it possible in clinical practice?

摘要

著录项

相似文献

相关主题

期刊订阅